Edap Tms FOCL
NASDAQ FOCL
$4.16 -0.04 (-0.95%)
At close: Sep 10, 2026 · 4:00 PM EDT

Edap Tms (FOCL) Income from Continuing Operations (2009 - 2026)

Edap Tms' (FOCL) quarterly Income from Continuing Operations came in at -$14.4 million in Q2 2026, down 135.17% on a YoY basis from $41.0 million in Q2 2025, and down 58.67% quarter-over-quarter from -$9.1 million in Q1 2026.

Analysis

Edap Tms (FOCL) Income from Continuing Operations (2009 - 2026) Analysis & Trends

Edap Tms (FOCL) has reported Income from Continuing Operations for 18 consecutive years, with -$14.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Income from Continuing Operations fell 135.17% year-over-year to -$14.4 million; the trailing twelve-month figure through Jun 2026 stood at -$31.6 million (down 42.18% YoY), and the FY2025 full-year result was -$21.6 million, down 9.65% from the prior year.
  • Income from Continuing Operations declined to -$14.4 million in Q2 2026 per FOCL's latest filing, from -$9.1 million in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at $2.2 million in Q2 2022 and bottomed at -$14.4 million in Q2 2026.
  • Historically, Income from Continuing Operations has averaged -$4.9 million across 5 years, with a median of -$5.2 million in 2025.
  • The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations jumped 700.33% in 2022, then tumbled 1503.97% in 2023.
  • Over 5 years, Income from Continuing Operations stood at -$5.7 million in 2022, then grew by 17.18% to -$4.7 million in 2023, then surged by 56.23% to -$2.1 million in 2024, then decreased by 21.22% to -$2.5 million in 2025, then plunged by 472.13% to -$14.4 million in 2026.
  • According to Business Quant data, Income from Continuing Operations over the past three periods registered -$14.4 million, -$9.1 million, and -$2.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 823.20 Mn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 1.48 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 905.00 Mn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 241.40 Mn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn -92.00 Mn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 249.10 Mn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 201.00 Mn
10 Edap Tms 156.12 Mn 134.57 Mn 7.34 Mn -14.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -14.41 Mn
Mar 31, 2026 -9.08 Mn
Dec 31, 2025 -2.52 Mn
Sep 30, 2025 -5.62 Mn
Jun 30, 2025 -6.13 Mn
Mar 31, 2025 -7.15 Mn
Dec 31, 2024 -2.08 Mn
Sep 30, 2024 -6.89 Mn
Jun 30, 2024 -6.33 Mn
Mar 31, 2024 -4.70 Mn
Dec 31, 2023 -4.75 Mn
Sep 30, 2023 -4.20 Mn
Jun 30, 2023 -4.63 Mn
Mar 31, 2023 -7.94 Mn
Dec 31, 2022 -5.73 Mn
Sep 30, 2022 1.74 Mn
Jun 30, 2022 2.22 Mn
Mar 31, 2022 565,658.21
Dec 31, 2021 1.34 Mn
Sep 30, 2021 -935,174.85